首页> 外文OA文献 >SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

【2h】

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

机译：抗癌剂的SR-B1靶向纳米次数：一种治疗三重阴性乳腺癌的有希望的新方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rebecca Johnson; Nirupama Sabnis; Xiangle Sun; Ruhani Ahluwalia; Andras Lacko;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer [J] . Rebecca Johnson, Nirupama Sabnis, Xiangle Sun, Breast Cancer: Targets and Therapy . 2017,第1期

机译：SR-B1靶向抗癌药物的纳米递送：治疗三阴性乳腺癌的有前途的新方法
2. New 3-alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44(+/high)/CD24(-/low) subset of triple-negative breast cancer cell line [J] . de Lima Aline Brito, Barbosa Camila de Souza, Marques Neves Goncalves Alessandra Mirtes, Chemical biology and drug design . 2017,第1期

机译：新的3-烷基吡啶海洋生物碱类似物，作为对CD44（+ /高）/ CD24（ - /低）三重阴性乳腺癌细胞系的抗肿瘤剂的有前途的抗肿瘤剂
3. Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents [J] . Ganesan Prasanth, Moulder Stacy, Lee J. Jack, Molecular cancer therapeutics . 2014,第12期

机译：在MD安德森癌症中心进行的第一阶段试验中治疗的三阴性乳腺癌患者：联合化疗和靶向药物改善了结局
4. Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network [C] . Michael Ventoso, Kerri-Ann Norton IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：用三重阴性乳腺癌肿瘤和血管网络的基于组合药物的免疫应答模拟免疫应答
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer [O] . Rebecca Johnson, Nirupama Sabnis, Xiangle Sun, 2017

机译：SR-B1靶向抗癌药物的纳米递送：治疗三阴性乳腺癌的有前途的新方法
7. Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells [O] . Chyou-Wei Wei, Yung-Luen Yu, Ji-Ying Lu, 2019

机译：MDA-MB 231三重阴性乳腺癌细胞中磺基碱和维生素E琥珀酸酯的抗癌作用
8. Cotargeting the lncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for Treating Triple-Negative Breast Cancer. [R] . Yang, L. 2017

机译：共定位lncRNa-pIp3相互作用和aKT / pI3K信号轴：一种治疗三阴性乳腺癌的新范式。

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅